Overview

Effect of Food on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects

Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of the trial is to investigate the effect of food on the pharmacokinetics (the exposure of the trial drug in the body) of oral semaglutide, in a SNAC (sodium N-[8-(2-hydroxybenzoyl) amino] caprylate) tablet formulation with three different dosing conditions in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Novo Nordisk A/S